Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 163
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 61
Pharmaceuticals 50
Drug Discovery 48
Cardiovascular Drugs 46
Biopharmaceuticals 43
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 30
Clinical Trials 30
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 28
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,026 Results (Page 29 of 52)
- Relevance
  Sort by

Fibrotic Diseases Treatment Market - Global Forecast 2025-2032

 Report
November 2025
189 Pages
Global

From

€3450EUR$3,939USD£2,994GBP

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

 Report
October 2023
204 Pages
Global

From

€3897EUR$4,450USD£3,383GBP

Preeclampsia Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Antibiotics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Cardiotonic Agents Market - Global Strategic Business Report

 Report
February 2026
568 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Angina Pectoris Drugs - Global Strategic Business Report

 Report
February 2026
196 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
February 2026
413 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

Inhaled Antibiotics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Non-alcoholic Steatohepatitis Clinical Trials - Global Strategic Business Report

 Report
February 2026
144 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

 Report
June 2024
103 Pages
Europe

From

€1927EUR$2,200USD£1,672GBP

Nanomedicine Market - Forecasts from 2023 to 2028

 Report
September 2023
146 Pages
Global

From

€3897EUR$4,450USD£3,383GBP

Hepatitis B Virus (HBV) Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
May 2025
180 Pages
Global

From

€3941EUR$4,500USD£3,421GBP

Multiple Myeloma Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
May 2025
200 Pages
Global

From

€2181EUR$2,490USD£1,893GBP

Pulmonary Embolism Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Condyloma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1752EUR$2,000USD£1,520GBP

Congestive Heart Failure Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3450EUR$3,939USD£2,994GBP

Candidiasis Drugs - Global Strategic Business Report

 Report
February 2026
250 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

Oral Antivirals Market - Global Strategic Business Report

 Report
February 2026
380 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

Bird Flu Treatment Market - Global Strategic Business Report

 Report
February 2026
285 Pages
Global

From

€5124EUR$5,850USD£4,447GBP

1,026 Results (Page 29 of 52)
- 1
- 27
- 28
- 29
- 30
- 31

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.